StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)

Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –

Novo Nordisk A S free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was 58.96B DKK, down 20.1% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is 83.10B DKK in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 202558.96B DKK-20.1%
FY2024Dec 31, 202473.80B DKK-11.2%
FY2023Dec 31, 202383.10B DKK+24.5%
FY2022Dec 31, 202266.74B DKK+37.1%
FY2021Dec 31, 202148.67B DKK+5.5%
FY2020Dec 31, 202046.13B DKK+21.9%
FY2019Dec 31, 201937.85B DKK+8.2%
FY2018Dec 31, 201834.98B DKK+4.3%
FY2017Dec 31, 201733.54B DKK-18.7%
FY2016Dec 31, 201641.25B DKK+24.7%
FY2015Dec 31, 201533.06B DKK–

More Novo Nordisk A S figures

See a number that looks wrong?